Ranking Invest

IBRX - ImmunityBio, Inc.

Segmento: HealthcareImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The company also develops therapeutic agents, which are in Phase II or III clinical trial for the treatment of liquid and solid tumors, including bladder, pancreatic, and lung cancers, as well as pathogens as SARS-CoV-2 and HIV. It has collaboration agreements with National Cancer Institute, National Institute of Deafness and Communication Disorders, and Amyris, Inc.; and license agreements with CytRx Corporation, EnGeneIC Pty Limited, GlobeImmune, Inc., and Infectious Disease Research Institute, Sanford Health, Shenzhen Beike Biotechnology Co. Ltd., Sorrento Therapeutics, Inc., and Viracta Therapeutics, Inc. The company was founded in 2014 and is based in San Diego, California.

Análise Ranking Invest

Valuation estimado
-$ 2.28 Bi
Valor de Mercado
$ 2.16 Bi
Desconto (AV)-194.4%
MLL
-0.79A companhia gerou lucro líquido equivalente a -79% do seu valor de mercado nos últimos 4 trimestres.
Último Balanço Atualizado: 1T2025

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

-$ 590.48 Mi

Dívida Líquida

-$ 20.10 Mi

L4T

-$ 409.10 Mi

MM4T

-3956.17%

Indicadores Básicos

ROE

69.28%

Índices de Previsibilidade

Faturamento

1.00

Lucro

0.17

Margem

0.84

Índices de Tendência

Faturamento

7.79

Lucro

-2.71

Margem

2.19

Índices de Endividamento

DIV/PAT

0.03

DIV/L4T

0.05

Dívidas
Cotação
Gráfico Lucro/Faturamento X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.